Epcoritamab Shows Promise in Large B-Cell Lymphoma
Epcoritamab elicits durable responses in patients with relapsed or refractory large B-cell lymphoma.
Diagnosis & Disease Information
Rapcabtagene Autoleucel Shows Activity in Relapsed/Refractory DLBCL
Rapcabtagene autoleucel may elicit durable responses in patients with relapsed/refractory diffuse large B-cell lymphoma.
Atezolizumab Plus R-CHOP Deemed Unworthy of Additional Study in Diffuse Large B-Cell Lymphoma
Results of a phase 1/2 trial suggest the combination of atezolizumab and R-CHOP does not warrant further study in DLBCL, according to researchers.
Tisagenlecleucel Plus Pembrolizumab May Be Effective in R/R DLBCL
Tisagenlecleucel plus pembrolizumab produced responses in patients with relapsed/refractory diffuse large B-cell lymphoma.
Orelabrutinib Plus R-CHOP Appears Active in Extranodal, Non-GCB DLBCL
The aim of this trial was to evaluate the efficacy and safety of orelabrutinib plus R-CHOP in patients with extranodal non-GCB DLBCL.
TPO Receptor Agonists for CAR T-Associated Persistent Cytopenia
Severe persistent cytopenia was resolved in 5 of 6 patients.
Pola-R-CHP May Be Cost Effective, Depending on PFS Outcomes in Previously Untreated DLBCL
Researchers sought to determine whether combination pola-R-CHP would be cost-effective for patients with previously untreated DLBCL.
Bortezomib Provides No Benefit Over R-DHAP Alone in R/R DBLCL
Overall, there was no improvement in complete response or survival outcomes among patients who received bortezomib.
Hematologists Avoid Guideline-Recommended Repeat Biopsies in Rel/Ref Diffuse Large B-Cell Lymphoma
A large proportion of patients with relapsed/refractory diffuse large B-cell lymphoma do not undergo repeat biopsy, a study suggests.
Prognostic Model Predicts Survival in Elderly With GI Diffuse Large B-Cell Lymphoma
A model including 4 clinical factors can predict overall survival, with predictive performance superior to the Ann Arbor staging system.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...